Michael T. Constantino Humacyte, Inc. (HUMA) insider trading activity

Michael T. Constantino is Director of Humacyte, Inc.. Currently has a direct ownership of 32,950 shares of HUMA, which is worth approximately $49,095. The most recent transaction as insider was on Apr 07, 2025, when has been sold 16,000 shares (Common Stock) at a price of $1.26 per share, resulting in proceeds of $20,160. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33K

94.4% 3M change

256.22% 12M change

Total Value Held $49,095

Michael T. Constantino Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 07 2025	BUY Open market or private purchase	$20,160 $1.26 p/Share	16,000 Added 32.69%	32,950 Common Stock
Dec 04 2024	BUY Open market or private purchase	$20,194 $4.39 p/Share	4,600 Added 21.35%	16,950 Common Stock
Aug 15 2024	BUY Open market or private purchase	$19,499 $6.29 p/Share	3,100 Added 20.06%	12,350 Common Stock
May 18 2023	BUY Open market or private purchase	$19,855 $4.18 p/Share	4,750 Added 33.93%	9,250 Common Stock
May 23 2022	BUY Open market or private purchase	$9,660 $4.83 p/Share	2,000 Added 30.77%	4,500 Common Stock
Nov 22 2021	BUY Open market or private purchase	$27,025 $10.81 p/Share	2,500 Added 50.0%	2,500 Common Stock

Also insider at

NMTR

9 METERS BIOPHARMA, INC. Healthcare

Director

MTC